Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Effect of antioxidant therapy on hepatic fibrosis and liver iron concentrations in β-thalassemia major patients.

Elalfy MS, Adly AA, Attia AA, Ibrahim FA, Mohammed AS, Sayed AM.

Hemoglobin. 2013;37(3):257-76. doi: 10.3109/03630269.2013.778866. Epub 2013 Apr 9.

PMID:
23565660
2.

Liver fibrosis in young Egyptian beta-thalassemia major patients: relation to hepatitis C virus and compliance with chelation.

Elalfy MS, Esmat G, Matter RM, Abdel Aziz HE, Massoud WA.

Ann Hepatol. 2013 Jan-Feb;12(1):54-61.

3.

The benefits of vitamin C and vitamin E in children with beta-thalassemia with high oxidative stress.

Dissayabutra T, Tosukhowong P, Seksan P.

J Med Assoc Thai. 2005 Sep;88 Suppl 4:S317-21.

PMID:
16623048
4.

Antioxidant status in patients with cystic fibrosis.

Madarasi A, Lugassi A, Greiner E, Holics K, Biró L, Mozsáry E.

Ann Nutr Metab. 2000;44(5-6):207-11.

PMID:
11146325
5.

Oxidative stress and antioxidant status in beta-thalassemia major: iron overload and depletion of lipid-soluble antioxidants.

Livrea MA, Tesoriere L, Pintaudi AM, Calabrese A, Maggio A, Freisleben HJ, D'Arpa D, D'Anna R, Bongiorno A.

Blood. 1996 Nov 1;88(9):3608-14.

6.

Peroxidative stress and antioxidant enzymes in children with beta-thalassemia major.

Naithani R, Chandra J, Bhattacharjee J, Verma P, Narayan S.

Pediatr Blood Cancer. 2006 Jun;46(7):780-5.

PMID:
16317757
7.

Attenuation of oxidative stress-induced changes in thalassemic erythrocytes by vitamin E.

Das N, Das Chowdhury T, Chattopadhyay A, Datta AG.

Pol J Pharmacol. 2004 Jan-Feb;56(1):85-96.

8.

Antioxidant status in beta thalassemia major: a single-center study.

Waseem F, Khemomal KA, Sajid R.

Indian J Pathol Microbiol. 2011 Oct-Dec;54(4):761-3. doi: 10.4103/0377-4929.91489.

9.

Effect of coenzyme Q10 as an antioxidant in beta-thalassemia/Hb E patients.

Kalpravidh RW, Wichit A, Siritanaratkul N, Fucharoen S.

Biofactors. 2005;25(1-4):225-34.

PMID:
16873951
10.

Improvement in oxidative stress and antioxidant parameters in beta-thalassemia/Hb E patients treated with curcuminoids.

Kalpravidh RW, Siritanaratkul N, Insain P, Charoensakdi R, Panichkul N, Hatairaktham S, Srichairatanakool S, Phisalaphong C, Rachmilewitz E, Fucharoen S.

Clin Biochem. 2010 Mar;43(4-5):424-9. doi: 10.1016/j.clinbiochem.2009.10.057. Epub 2009 Nov 10.

PMID:
19900435
11.

Serum and dietary antioxidant status is associated with lower prevalence of the metabolic syndrome in a study in Shanghai, China.

Li Y, Guo H, Wu M, Liu M.

Asia Pac J Clin Nutr. 2013;22(1):60-8. doi: 10.6133/apjcn.2013.22.1.06.

12.

Improvement in liver pathology of patients with β-thalassemia treated with deferasirox for at least 3 years.

Deugnier Y, Turlin B, Ropert M, Cappellini MD, Porter JB, Giannone V, Zhang Y, Griffel L, Brissot P.

Gastroenterology. 2011 Oct;141(4):1202-11, 1211.e1-3. doi: 10.1053/j.gastro.2011.06.065. Epub 2011 Jul 7. Erratum in: Gastroenterology. 2012 Jan;142(1):186.

PMID:
21741344
13.

Endogenous antioxidant activities in relation to concurrent vitamins A, C, and E intake in dementia.

Tabet N, Mantle D, Walker Z, Orrell M.

Int Psychogeriatr. 2002 Mar;14(1):7-15.

PMID:
12094909
14.

Effect of vitamin E and C supplements on antioxidant defense system in cardiovascular disease patients in Zahedan, southeast Iran.

Karajibani M, Hashemi M, Montazerifar F, Dikshit M.

J Nutr Sci Vitaminol (Tokyo). 2010;56(6):436-40.

15.

Iron overload and antioxidant status in patients with beta-thalassemia major.

Reller K, Dresow B, Collell M, Fischer R, Engelhardt R, Nielsen P, Dürken M, Politis C, Piga A.

Ann N Y Acad Sci. 1998 Jun 30;850:463-5. No abstract available.

PMID:
9668585
16.
17.
18.

Hepcidin levels and iron status in beta-thalassemia major patients with hepatitis C virus infection.

Hendy OM, Allam M, Allam A, Attia MH, El Taher S, Eldin MM, Ali A.

Egypt J Immunol. 2010;17(2):33-44.

PMID:
23082485
19.

Oral supplements of vitamin E improve measures of oxidative stress in plasma and reduce oxidative damage to LDL and erythrocytes in beta-thalassemia intermedia patients.

Tesoriere L, D'Arpa D, Butera D, Allegra M, Renda D, Maggio A, Bongiorno A, Livrea MA.

Free Radic Res. 2001 May;34(5):529-40.

PMID:
11378535
20.
Items per page

Supplemental Content

Write to the Help Desk